Biotech Strategy Blog

Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Cancer Immunotherapy

  • Posts
    • ESMO16
    • ECC 2015
    • ESMO14
    • ECC 2013
    • AACR17
    • AACR16
    • AACR15
    • AACR14
    • AAI ASGCT 2015 New Orleans
    • ASCO-SITC
    • ASCO17
    • ASCO16
    • ASCO15
    • ASCO14
    • ASCO GI 2017
    • ASCO GU CI 2016
    • ASCO GI GU 2015
    • ASCO GI GU 2014
    • ASH16
    • ASH15
    • ASH14
    • ASH13
    • AUA 2015
    • AUA 2014
    • BMT Tandem
    • CIML40
    • EACR
    • EAU 2015 Congress
    • EBMT15
    • European Breast Cancer Conference
    • European Lung Cancer Conf
    • JPM17
    • JPM15
    • JPM14
    • Miami Breast Cancer Conference
    • Mol Targets 2016
    • Molecular Targets
    • SABCS16
    • SABCS15
    • SABCS14
    • SABCS13
    • SITC 2016
    • SITC 2015
    • SITC 2014
  • About
  • Contact
  • Expert Interviews
  • Immuno-Oncology
  • ESMO17
  • Premium Content
  • Pricing
  • Login

  • ESMO17 Preview 1 – The IO 5

    Read more

  • How to revolutionize cancer immunotherapy trials

    Read more

  • Exploring pre-existing immunity in cancer immunotherapy trials

    Read more

  • Jumpstarting the immune system with synthetic immunity

    Read more

  • A hidden gem at ASCO17

    Read more

  • MYSTIC Interim Analysis July 2017 shows PFS Miss

    Read more

  • A look at why we get mixed results with phase 3 checkpoint trials

    Read more

  • A look at Nektar Therapeutics immunotherapy pipeline

    Read more
E

ESMO17 Preview 1 – The IO 5

Top 5 IO oral abstracts to watch out for in Madrid

View post
E

How to revolutionize cancer immunotherapy trials

A look at various factors that can influence cancer immunotherapy trials through the lens of an immunologist

View post
E

Exploring pre-existing immunity in cancer immunotherapy trials

A look at the role of pre-existing immunity in cancer immunotherapy trial readouts at ASCO17

View post

Terms of Use
Copyright © 2010-17 Biotech Strategy Blog

✕
Sign Up for Deals and News Alerts
error: Content is protected !!